Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
Authors
Keywords
-
Journal
SUPPORTIVE CARE IN CANCER
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-20
DOI
10.1007/s00520-018-4553-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data
- (2018) Ellen M. Lavoie Smith et al. CANCER NURSING
- Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
- (2017) Jacobien M. Kieffer et al. QUALITY OF LIFE RESEARCH
- Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials
- (2017) Jennifer Le-Rademacher et al. SUPPORTIVE CARE IN CANCER
- Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
- (2016) Ting Bao et al. BREAST CANCER RESEARCH AND TREATMENT
- Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population
- (2016) Floortje Mols et al. EUROPEAN JOURNAL OF CANCER
- Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment
- (2016) Noah R. Zanville et al. SUPPORTIVE CARE IN CANCER
- Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS©)
- (2015) Els K. Vanhoutte et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy
- (2015) Davide Binda et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses
- (2015) Thomas H. P. Draak et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Reliability and Validity of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to Assess Chemotherapy-induced Peripheral Neuropathy
- (2015) Hye Young Kim et al. Journal of Korean Academy of Nursing
- North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study
- (2014) Alexis D. Leal et al. CANCER
- Overview of Classical Test Theory and Item Response Theory for the Quantitative Assessment of Items in Developing Patient-Reported Outcomes Measures
- (2014) Joseph C. Cappelleri et al. CLINICAL THERAPEUTICS
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis
- (2014) Reza Sadjadi et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
- (2013) P. Alberti et al. ANNALS OF ONCOLOGY
- Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
- (2013) D. Binda et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
- (2013) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors
- (2013) Cindy Tofthagen et al. SUPPORTIVE CARE IN CANCER
- Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
- (2013) Rebecca M. Speck et al. Journal of Oncology Practice
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy
- (2012) Brandi N. Reeves et al. CANCER
- Outcome measures in peripheral neuropathies
- (2012) Ingemar S.J. Merkies et al. CURRENT OPINION IN NEUROLOGY
- Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
- (2011) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
- (2011) S. I. van Nes et al. NEUROLOGY
- Falls in persons with chemotherapy-induced peripheral neuropathy
- (2011) Cindy Tofthagen et al. SUPPORTIVE CARE IN CANCER
- The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
- (2010) Ellen M. Lavoie Smith et al. CANCER NURSING
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
- (2010) Debra L. Barton et al. SUPPORTIVE CARE IN CANCER
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now